085660 — Chabiotech Co Income Statement
0.000.00%
Last trade - 00:00- KR₩697bn
- KR₩2tn
- KR₩1tn
Annual income statement for Chabiotech Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 664,717 | 727,476 | 844,583 | 953,951 | 1,045,049 |
| Cost of Revenue | |||||
| Gross Profit | 190,930 | 216,639 | 204,554 | 276,372 | 275,256 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 670,691 | 720,053 | 905,322 | 961,573 | 1,092,998 |
| Operating Profit | -5,974 | 7,423 | -60,739 | -7,622 | -47,949 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -30,981 | -10,033 | -71,302 | 3,188 | -6,204 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -34,179 | -21,844 | -69,659 | -5,560 | -14,550 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -18,658 | -13,968 | -47,543 | -8,431 | -8,054 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -18,658 | -13,968 | -47,543 | -8,431 | -8,054 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -288 | -226 | -636 | -159 | -262 |
| Dividends per Share |